Immunoglobulin News and Research

RSS
Combination treatment can benefit children with Kawasaki disease

Combination treatment can benefit children with Kawasaki disease

Gut microbiome may play a part in severe COVID-19

Gut microbiome may play a part in severe COVID-19

COVID immunity related to how bad you get it

COVID immunity related to how bad you get it

Absolute Antibody offers SARS-CoV-2 neutralizing antibodies derived from COVID-19 patients

Absolute Antibody offers SARS-CoV-2 neutralizing antibodies derived from COVID-19 patients

Majority of recovered COVID-19 patients have low neutralizing antibody titers

Majority of recovered COVID-19 patients have low neutralizing antibody titers

Pre-COVID-19 coronavirus immunity does not protect against SARS-CoV-2

Pre-COVID-19 coronavirus immunity does not protect against SARS-CoV-2

Scientists claim signs of lasting SARS-CoV-2 immunity

Scientists claim signs of lasting SARS-CoV-2 immunity

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

SARS-CoV-2 infection and transmission possible in North American deer mice

SARS-CoV-2 infection and transmission possible in North American deer mice

Only half of pregnant women worldwide get treatment for preventable Rh disease

Only half of pregnant women worldwide get treatment for preventable Rh disease

Evidence for antibody longevity in COVID-19 patients

Evidence for antibody longevity in COVID-19 patients

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2

Pre-COVID-19 coronavirus antibodies fail to neutralize SARS-CoV-2

Pre-COVID-19 coronavirus antibodies fail to neutralize SARS-CoV-2

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Common antioxidant enzyme catalase as COVID-19 treatment

Common antioxidant enzyme catalase as COVID-19 treatment

Antibodies to SARS-CoV-2 disappear within three months

Antibodies to SARS-CoV-2 disappear within three months

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Serology distinguishes children with MIS-C associated with COVID-19

Serology distinguishes children with MIS-C associated with COVID-19

Novel antibody test for SARS-CoV-2

Novel antibody test for SARS-CoV-2